HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting
| Autor: | Perrone, V, Iacolare, B, Dovizio, M, Andretta, M, Bacca, M, Barbieri, A, Bartolini, F, Cavaliere, A, Chinellato, A, Ciaccia, A, Cillo, MR, Costantini, A, Dell'Orco, S, Ferrante, F, Gentile, S, Grego, S, Lavalle, A, Maccio, S, Mancini, D, Moscogiuri, R, Mosele, E, Pagliaro, R, Pastorello, M, Procacci, C, Re, D, Santoleri, F, Ubertazzo, L, Vercellone, A, Degli Esposti, L |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S275-S276 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect